Considering their unique effector functions and the abundance of MΦs in the brain [19, 26], we hypothesized that genetic programming of the intratumour MΦs with BSG-specific CAR could redefine their phagocytic activity and antigen presenting functions to stimulate an adaptive immune response against BSG, thus promoting tumor remission. The gene discussed is BSG; the disease is neoplasm.